Including pork in the Mediterranean diet for an Australian population: Protocol for a randomised controlled trial assessing cardiovascular risk and cognitive function.
Study Goal
The researchers aimed to assess the cardiovascular and cognitive benefits of a modified Mediterranean diet that includes moderate dairy consumption, among other dietary components, in an at-risk population.
Results Summary
The abstract does not provide specific results regarding dairy's effects, as the focus was on the overall dietary pattern and the inclusion of lean pork as an alternate protein source.
Population
At-risk men and women (specifics not detailed beyond this).
Effective Dosage
Not specified for dairy (moderate consumption implied by Mediterranean diet guidelines).
Duration
8 weeks per diet (with an 8-week washout period).
Interactions
None mentioned.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Mediterranean diet | decrease | cardiovascular disease | - | - | may be effective for the prevention | #1 |
Mediterranean diet | decrease | dementia | - | - | may be effective for the prevention | #2 |
Mediterranean diet modified to include 2-3 weekly serves of fresh, lean pork | increase | cardiovascular benefits | at-risk men and women | - | will assess the cardiovascular and cognitive benefits | #3 |
Mediterranean diet modified to include 2-3 weekly serves of fresh, lean pork | increase | cognitive benefits | at-risk men and women | - | will assess the cardiovascular and cognitive benefits | #4 |
Mediterranean diet modified to include 2-3 weekly serves of fresh, lean pork | increase | sustainability | non-Mediterranean population | - | to increase sustainability and feasibility | #5 |
Mediterranean diet modified to include 2-3 weekly serves of fresh, lean pork | increase | feasibility | non-Mediterranean population | - | to increase sustainability and feasibility | #6 |
Mediterranean diet modified to include 2-3 weekly serves of fresh, lean pork | decrease | cardiovascular disease | - | - | Findings will be significant for the prevention | #7 |
Mediterranean diet modified to include 2-3 weekly serves of fresh, lean pork | decrease | age-related decline | - | - | Findings will be significant for the prevention | #8 |
BACKGROUND: The Mediterranean diet is characterised by the high consumption of extra virgin olive oil, fruits, vegetables, grains, legumes and nuts; moderate consumption of fish, poultry, eggs and dairy; and low consumption of red meat and sweets. Cross sectional, longitudinal and intervention studies indicate that a Mediterranean diet may be effective for the prevention of cardiovascular disease and dementia. However, previous research suggests that an Australian population may find red meat restrictions difficult, which could affect long term sustainability of the diet. METHODS: This paper outlines the protocol for a randomised controlled trial that will assess the cardiovascular and cognitive benefits of a Mediterranean diet modified to include 2-3 weekly serves of fresh, lean pork. A 24-week cross-over design trial will compare a modified Mediterranean diet with a low-fat control diet in at-risk men and women. Participants will follow each of the two diets for 8 weeks, with an 8-week washout period separating interventions. Home measured systolic blood pressure will be the primary outcome measure. Secondary outcomes will include body mass index, body composition, fasting blood lipids, C-reactive protein, fasting plasma glucose, fasting serum insulin, erythrocyte fatty acids, cognitive function, psychological health and well-being, and dementia risk. DISCUSSION: To our knowledge this research is the first to investigate whether an alternate source of protein can be included in the Mediterranean diet to increase sustainability and feasibility for a non-Mediterranean population. Findings will be significant for the prevention of cardiovascular disease and age-related decline, and may inform individuals, clinicians and public health policy. TRIAL REGISTRATION: ACTRN12616001046493 . Registered 5 August 2016.